Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenji Maeda

Showing results (51-60 of 233) with videos related to

Pageof 24
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 18, 2004
[Method for home parenteral nutrition (HPN) at Daikou Sunadabashi Clinic]Yuka Sugimoto, Masako It, Kayoko Hotta, et al.
Cell|May 4, 2020
SnapShot: Lysosomal FunctionsLya K K Holland, Inger Ødum Nielsen, Kenji Maeda, et al.
FEBS Letters|July 3, 2010
Kinetic and thermodynamic properties of two barley thioredoxin h isozymes, HvTrxh1 and HvTrxh2Kenji Maeda, Per Hägglund, Olof Björnberg, et al.
Physical Review Letters|February 25, 2017
Interaction-Assisted Quantum Tunneling of a Bose-Einstein Condensate Out of a Single Trapping WellShreyas Potnis, Ramon Ramos, Kenji Maeda, et al.
Internal Medicine (Tokyo, Japan)|March 24, 2007
Minimal use of antibiotics for acute respiratory tract infections: validity and patient satisfactionKeisuke Tomii, Yoshihisa Matsumura, Kenji Maeda, et al.
Current Opinion in Pharmacology|September 8, 2004
The current status of, and challenges in, the development of CCR5 inhibitors as therapeutics for HIV-1 infectionKenji Maeda, Hirotomo Nakata, Hiromi Ogata, et al.
Computational and Structural Biotechnology Journal|July 8, 2024
Acidic sphingomyelinase interactions with lysosomal membranes and cation amphiphilic drugs: A molecular dynamics investigationSimone Scrima, Matteo Lambrughi, Lorenzo Favaro, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|November 19, 2019
[Preclinical pharmacological profiles and clinical efficacy of the novel antipsychotic drug brexpiprazole (REXULTI<sup>®</sup> Tablets 1 mg, 2 mg)]Mikio Suzuki, Kazunari Niidome, Kenji Maeda, et al.
Nephron|October 26, 2002
Which Kt/V is the most valid for assessment of both long mild and short intensive hemodialyses?Toshihiko Miwa, Shigeru Nakai, Masamiki Miwa, et al.
Progress in Lipid Research|December 15, 2015
The orchestra of lipid-transfer proteins at the crossroads between metabolism and signalingAntonella Chiapparino, Kenji Maeda, Denes Turei, et al.
Pageof 24

Showing results (51-60 of 233) with videos related to

Sort By:
Pageof 24
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 18, 2004
[Method for home parenteral nutrition (HPN) at Daikou Sunadabashi Clinic]Yuka Sugimoto, Masako It, Kayoko Hotta, et al.
Cell|May 4, 2020
SnapShot: Lysosomal FunctionsLya K K Holland, Inger Ødum Nielsen, Kenji Maeda, et al.
FEBS Letters|July 3, 2010
Kinetic and thermodynamic properties of two barley thioredoxin h isozymes, HvTrxh1 and HvTrxh2Kenji Maeda, Per Hägglund, Olof Björnberg, et al.
Physical Review Letters|February 25, 2017
Interaction-Assisted Quantum Tunneling of a Bose-Einstein Condensate Out of a Single Trapping WellShreyas Potnis, Ramon Ramos, Kenji Maeda, et al.
Internal Medicine (Tokyo, Japan)|March 24, 2007
Minimal use of antibiotics for acute respiratory tract infections: validity and patient satisfactionKeisuke Tomii, Yoshihisa Matsumura, Kenji Maeda, et al.
Current Opinion in Pharmacology|September 8, 2004
The current status of, and challenges in, the development of CCR5 inhibitors as therapeutics for HIV-1 infectionKenji Maeda, Hirotomo Nakata, Hiromi Ogata, et al.
Computational and Structural Biotechnology Journal|July 8, 2024
Acidic sphingomyelinase interactions with lysosomal membranes and cation amphiphilic drugs: A molecular dynamics investigationSimone Scrima, Matteo Lambrughi, Lorenzo Favaro, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|November 19, 2019
[Preclinical pharmacological profiles and clinical efficacy of the novel antipsychotic drug brexpiprazole (REXULTI<sup>®</sup> Tablets 1 mg, 2 mg)]Mikio Suzuki, Kazunari Niidome, Kenji Maeda, et al.
Nephron|October 26, 2002
Which Kt/V is the most valid for assessment of both long mild and short intensive hemodialyses?Toshihiko Miwa, Shigeru Nakai, Masamiki Miwa, et al.
Progress in Lipid Research|December 15, 2015
The orchestra of lipid-transfer proteins at the crossroads between metabolism and signalingAntonella Chiapparino, Kenji Maeda, Denes Turei, et al.
Pageof 24